Document Detail

Pathophysiology and treatment of diabetic retinopathy.
MedLine Citation:
PMID:  23277338     Owner:  NLM     Status:  Publisher    
In the past years, the management of diabetic retinopathy (DR) relied primarily on a good systemic control of diabetes mellitus, and as soon as the severity of the vascular lesions required further treatment, laser photocoagulation or vitreoretinal surgery was done to the patient. Currently, even if the intensive metabolic control is still mandatory, a variety of different clinical strategies could be offered to the patient. The recent advances in understanding the complex pathophysiology of DR allowed the physician to identify many cell types involved in the pathogenesis of DR and thus to develop new treatment approaches. Vasoactive and proinflammatory molecules, such as vascular endothelial growth factor (VEGF), play a key role in this multifactorial disease. Current properly designed trials, evaluating agents targeting VEGF or other mediators, showed benefits in the management of DR, especially when metabolic control is lacking. Other agents, directing to the processes of vasopermeability and angiogenesis, are under investigations, giving more hope in the future management of this still sight-threatening disease.
Francesco Bandello; Rosangela Lattanzio; Ilaria Zucchiatti; Claudia Del Turco
Related Documents :
23596808 - Essential factors of sui zheng shi liang strategy in type 2 diabetes treatment assessed...
23130988 - The diabetes pearl: diabetes biobanking in the netherlands.
25014878 - Diagnostic efficiency of hemoglobin a1c for newly diagnosed diabetes and prediabetes in...
23404598 - Multiple medication use in diabetic patients aged.
24889188 - Prostaglandin e1 alleviates neuropathic pain and neural dysfunction from entrapment neu...
8600618 - Normalization of diabetes by xenotransplantation of cryopreserved microencapsulated pan...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-1
Journal Detail:
Title:  Acta diabetologica     Volume:  -     ISSN:  1432-5233     ISO Abbreviation:  Acta Diabetol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9200299     Medline TA:  Acta Diabetol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Ophthalmology, Scientific Institute San Raffaele, University Vita-Salute, Via Olgettina 60, Milan, Italy,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects.
Next Document:  Representations in working memory yield interference effects found with externally-triggered represe...